Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jan 20, 2023
- Accession no.
- 0001415889-23-001275
- Filed
- Jan 20, 2023
- Trade date
- Jan 18-19, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.16M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (CHAIRPERSON & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 18, 2023 | Common Stock | MOption exerciseAcquired | +8,000 | $113.08 | +$904,640 | 8,130 | Direct | |
| Jan 18, 2023 | Common Stock | SSaleDisposed | −3,152 | $259.22F2 | −$817,061.44 | 4,978 | Direct | |
| Jan 18, 2023 | Common Stock | SSaleDisposed | −2,471 | $259.99F3 | −$642,435.29 | 2,507 | Direct | |
| Jan 18, 2023 | Common Stock | SSaleDisposed | −1,745 | $260.91F4 | −$455,287.95 | 762 | Direct | |
| Jan 18, 2023 | Common Stock | SSaleDisposed | −553 | $262.00F5 | −$144,886 | 209 | Direct | |
| Jan 18, 2023 | Common Stock | SSaleDisposed | −79 | $262.90F6 | −$20,769.1 | 130 | Direct | |
| Jan 19, 2023 | Common Stock | MOption exerciseAcquired | +8,000 | $113.08 | +$904,640 | 8,130 | Direct | |
| Jan 19, 2023 | Common Stock | SSaleDisposed | −3,761 | $259.15F7 | −$974,663.15 | 4,369 | Direct | |
| Jan 19, 2023 | Common Stock | SSaleDisposed | −4,172 | $259.98F8 | −$1,084,636.56 | 197 | Direct | |
| Jan 19, 2023 | Common Stock | SSaleDisposed | −67 | $261.01 | −$17,487.67 | 130 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 18, 2023 | Common Stock | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 576,000 | Direct | |
| Jan 19, 2023 | Common Stock | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 568,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $258.55 to $259.545. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $259.55 to $260.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $260.58 to $261.495. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $261.60 to $262.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $262.835 to $262.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $258.695 to $259.655. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $259.70 to $260.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.